0000950123-22-006503.txt : 20220516 0000950123-22-006503.hdr.sgml : 20220516 20220516163314 ACCESSION NUMBER: 0000950123-22-006503 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20220331 FILED AS OF DATE: 20220516 DATE AS OF CHANGE: 20220516 EFFECTIVENESS DATE: 20220516 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Ponoi II Management, LLC CENTRAL INDEX KEY: 0001746488 IRS NUMBER: 824521397 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-19918 FILM NUMBER: 22929886 BUSINESS ADDRESS: STREET 1: 1 LETTERMAN DRIVE STREET 2: BUILDING D, SUITE M-900 CITY: SAN FRANCISCO STATE: CA ZIP: 94129 BUSINESS PHONE: 415-865-2050 MAIL ADDRESS: STREET 1: 1 LETTERMAN DRIVE STREET 2: BUILDING D, SUITE M-900 CITY: SAN FRANCISCO STATE: CA ZIP: 94129 13F-HR 1 primary_doc.xml 13F-HR LIVE 0001746488 XXXXXXXX 03-31-2022 03-31-2022 false Ponoi II Management, LLC

1 Letterman Drive Building D, Suite M-900 San Francisco CA 94129

13F HOLDINGS REPORT 028-19918 Y Certain shares holdings that are reported on this 13F were previously reported on a 13F filed by Peter Svennilson (CIK: 0001606074) (File No. 028-16412) James Evangelista (415) 865-2050 /s/ James Evangelista San Francisco CA 05-16-2022 0 4 45063 false INFORMATION TABLE 2 13700.xml INFORMATION TABLE FOR FORM 13F Revolution Medicines Inc COM 76155X100 17475 685011 SH SOLE 685011 0 0 RAPT Therapeutics Inc COM 75382E109 3197 145401 SH SOLE 145401 0 0 NGM Biopharmaceuticals Inc COM 62921N105 19808 1298908 SH SOLE 1298908 0 0 Nurix Therapeutics Inc COM 67080M103 4583 327123 SH SOLE 327123 0 0